News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,918 Results
Type
Article (10974)
Company Profile (62)
Press Release (181882)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (53978)
Career Advice (302)
Deals (8816)
Drug Delivery (24)
Drug Development (16694)
Employer Resources (34)
FDA (4706)
Job Trends (5078)
News (87516)
Policy (8705)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1070)
Academic (1)
Accelerated approval (8)
Adcomms (1)
Allergies (49)
Alliances (15586)
ALS (53)
Alzheimer's disease (427)
Antibody-drug conjugate (ADC) (72)
Approvals (4912)
Artificial intelligence (136)
Autoimmune disease (32)
Automation (34)
Bankruptcy (70)
Best Places to Work (3826)
BIOSECURE Act (1)
Biosimilars (47)
Biotechnology (36)
Bladder cancer (74)
Brain cancer (14)
Breast cancer (207)
Cancer (1421)
Cardiovascular disease (92)
Career advice (278)
Career pathing (6)
CAR-T (60)
CDC (3)
Celiac Disease (1)
Cell therapy (142)
Cervical cancer (10)
Clinical research (14401)
Collaboration (531)
Company closure (1)
Compensation (75)
Complete response letters (10)
COVID-19 (818)
CRISPR (24)
C-suite (280)
Cystic fibrosis (46)
Data (1699)
Decentralized trials (1)
Denatured (1)
Depression (17)
Dermatology (17)
Diabetes (98)
Diagnostics (3925)
Digital health (17)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (86)
Drug pricing (23)
Drug shortages (10)
Duchenne muscular dystrophy (98)
Earnings (16550)
Editorial (6)
Employer branding (4)
Employer resources (31)
Events (21570)
Executive appointments (299)
FDA (5489)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (7)
Frontotemporal dementia (3)
Funding (360)
Gene editing (42)
Generative AI (9)
Gene therapy (156)
GLP-1 (208)
Government (1306)
Grass and pollen (5)
Guidances (77)
Healthcare (4989)
HIV (32)
Huntington's disease (3)
IgA nephropathy (23)
Immunology and inflammation (25)
Immuno-oncology (11)
Indications (43)
Infectious disease (916)
Inflammatory bowel disease (53)
Influenza (49)
Intellectual property (41)
Interviews (37)
IPO (3138)
IRA (6)
Job creations (1414)
Job search strategy (256)
JPM (12)
Kidney cancer (2)
Labor market (22)
Layoffs (103)
Leadership (7)
Legal (2079)
Liver cancer (12)
Longevity (5)
Lung cancer (219)
Lymphoma (124)
Machine learning (12)
Management (11)
Manufacturing (347)
MASH (25)
Medical device (3296)
Medtech (3314)
Mergers & acquisitions (5961)
Metabolic disorders (198)
mRNA (29)
Multiple sclerosis (38)
NASH (2)
Neurodegenerative disease (65)
Neuropsychiatric disorders (7)
Neuroscience (697)
NextGen: Class of 2026 (1819)
Non-profit (1422)
Now hiring (34)
Obesity (73)
Opinion (34)
Ovarian cancer (44)
Pain (59)
Pancreatic cancer (58)
Parkinson's disease (70)
Partnered (9)
Patents (80)
Patient recruitment (102)
Peanut (30)
People (18552)
Pharmaceutical (16)
Pharmacy benefit managers (2)
Phase 1 (3774)
Phase 2 (5496)
Phase 3 (6031)
Pipeline (1717)
Policy (21)
Postmarket research (674)
Preclinical (1766)
Press Release (20)
Prostate cancer (63)
Psychedelics (5)
Radiopharmaceuticals (88)
Rare diseases (206)
Real estate (3185)
Recruiting (14)
Regulatory (6434)
Reports (15)
Research institute (1017)
Resumes & cover letters (29)
Rett syndrome (3)
RSV (20)
Schizophrenia (17)
Series A (62)
Series B (31)
Sickle cell disease (25)
Special edition (5)
Spinal muscular atrophy (51)
Sponsored (12)
Startups (1069)
State (1)
Stomach cancer (3)
Supply chain (42)
Tariffs (14)
The Weekly (2)
Vaccines (167)
Venture capital (12)
Weight loss (52)
Women's health (21)
Worklife (2)
Date
Last 7 days (137)
Last 30 days (560)
Last 365 days (6499)
2026 (1758)
2025 (6550)
2024 (7946)
2023 (9287)
2022 (16970)
2021 (17723)
2020 (16797)
2019 (13013)
2018 (10053)
2017 (8970)
2016 (8966)
2015 (9832)
2014 (7724)
2013 (6667)
2012 (7291)
2011 (7451)
2010 (6564)
Location
Africa (215)
Alabama (15)
Alaska (4)
Arizona (71)
Arkansas (3)
Asia (10101)
Australia (1787)
California (2249)
Canada (888)
China (157)
Colorado (111)
Connecticut (97)
Delaware (142)
Europe (26088)
Florida (381)
Georgia (57)
Hawaii (1)
Idaho (14)
Illinois (363)
India (30)
Indiana (139)
Iowa (10)
Japan (130)
Kansas (34)
Kentucky (14)
Louisiana (14)
Maine (29)
Maryland (248)
Massachusetts (1523)
Michigan (116)
Minnesota (121)
Mississippi (2)
Missouri (78)
Montana (11)
Nebraska (7)
Nevada (26)
New Hampshire (17)
New Jersey (1032)
New Mexico (10)
New York (709)
North Carolina (641)
North Dakota (9)
Northern California (996)
Ohio (107)
Oklahoma (11)
Oregon (11)
Pennsylvania (362)
Puerto Rico (4)
Rhode Island (19)
South America (315)
South Carolina (24)
South Dakota (1)
Southern California (948)
Tennessee (73)
Texas (561)
United States (9336)
Utah (96)
Vermont (1)
Virginia (56)
Washington D.C. (18)
Washington State (192)
West Virginia (3)
Wisconsin (50)
192,918 Results for "charles river laboratories north carolina".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Laboratories Announces Executive Appointments
February 18, 2026
·
8 min read
Press Releases
Charles River Laboratories Provides Update on Planned Divestitures
February 25, 2026
·
9 min read
Press Releases
Charles River Laboratories to Present at TD Cowen and Barclays Conferences
March 2, 2026
·
1 min read
Manufacturing
J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina
Johnson & Johnson’s second facility in Wilson, North Carolina, is part of a $55 billion push to make all advanced medicines used in the U.S. domestically.
January 13, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Charles River Laboratories Provides Business Updates
January 13, 2026
·
14 min read
Press Releases
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
February 18, 2026
·
20 min read
Press Releases
Charles River Laboratories to Present at Evercore Healthcare Conference
December 2, 2025
·
1 min read
Press Releases
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
January 22, 2026
·
1 min read
Press Releases
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
January 8, 2026
·
11 min read
Press Releases
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
February 25, 2026
·
3 min read
1 of 19,292
Next
